Literature DB >> 31167979

A Novel Indicator for HDL Functionality.

Yasuhiro Irino1, Ryuji Toh1, Tatsuro Ishida2.   

Abstract

Entities:  

Keywords:  HDL functionality; High-density lipoprotein; Low-density lipoprotein receptor-1

Mesh：

Substances：

Year:  2019        PMID： 31167979      PMCID： PMC6845690          DOI： 10.5551/jat.ED111

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  10 in total

1.  Effects of orientational order and particle size on the NMR line positions of lipoproteins.

Authors: 
Journal:  Phys Rev Lett       Date:  1994-06-20       Impact factor: 9.161

Review 2.  The Changing Face of HDL and the Best Way to Measure It.

Authors:  Sotirios K Karathanasis; Lita A Freeman; Scott M Gordon; Alan T Remaley
Journal:  Clin Chem       Date:  2016-11-22       Impact factor: 8.327

3.  HDL cholesterol efflux capacity and incident cardiovascular events.

Authors:  Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

4.  Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.

Authors:  Ying Huang; Zhiping Wu; Meliana Riwanto; Shengqiang Gao; Bruce S Levison; Xiaodong Gu; Xiaoming Fu; Matthew A Wagner; Christian Besler; Gary Gerstenecker; Renliang Zhang; Xin-Min Li; Anthony J DiDonato; Valentin Gogonea; W H Wilson Tang; Jonathan D Smith; Edward F Plow; Paul L Fox; Diana M Shih; Aldons J Lusis; Edward A Fisher; Joseph A DiDonato; Ulf Landmesser; Stanley L Hazen
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

5.  A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids.

Authors:  M Navab; S Y Hama; G P Hough; G Subbanagounder; S T Reddy; A M Fogelman
Journal:  J Lipid Res       Date:  2001-08       Impact factor: 5.922

6.  Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.

Authors:  Yoko Haraguchi; Ryuji Toh; Minoru Hasokawa; Hideto Nakajima; Tomoyuki Honjo; Kazunori Otsui; Kenta Mori; Maki Miyamoto-Sasaki; Masakazu Shinohara; Kunihiro Nishimura; Tatsuro Ishida; Ken-Ichi Hirata
Journal:  Atherosclerosis       Date:  2014-03-19       Impact factor: 5.162

Review 7.  Assessment of HDL Cholesterol Removal Capacity: Toward Clinical Application.

Authors:  Ryuji Toh
Journal:  J Atheroscler Thromb       Date:  2018-12-12       Impact factor: 4.928

8.  A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL.

Authors:  Akemi Kakino; Yoko Usami; Sayaka Horiuchi; Yoshiko Fujita; Kazuhiko Kotani; Chu-Huang Chen; Tomonori Okamura; Tatsuya Sawamura
Journal:  J Atheroscler Thromb       Date:  2019-04-03       Impact factor: 4.928

Review 9.  High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk.

Authors:  Anouar Hafiane; Jacques Genest
Journal:  BBA Clin       Date:  2015-01-31

Review 10.  Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week.

Authors:  Jane Armitage; Michael V Holmes; David Preiss
Journal:  J Am Coll Cardiol       Date:  2019-02-05       Impact factor: 24.094
  10 in total
  3 in total

1.  Serum HDL cholesterol uptake capacity in subjects from the MASHAD cohort study: Its value in determining the risk of cardiovascular endpoints.

Authors:  Malihe Aghasizadeh; Sara Samadi; Amirhossein Sahebkar; Ebrahim Miri-Moghaddam; Habibollah Esmaily; Mohamad Souktanloo; Amir Avan; Amin Mansoori; Gordon A Ferns; Tooba Kazemi; Majid Ghayour-Mobarhan
Journal:  J Clin Lab Anal       Date:  2021-05-24       Impact factor: 2.352

2.  High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease.

Authors:  Fumiaki Ito; Tomoyuki Ito
Journal:  Antioxidants (Basel)       Date:  2020-04-26

Review 3.  Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?

Authors:  Susana Coimbra; Flávio Reis; Maria João Valente; Susana Rocha; Cristina Catarino; Petronila Rocha-Pereira; Maria Sameiro-Faria; Elsa Bronze-da-Rocha; Luís Belo; Alice Santos-Silva
Journal:  Biomedicines       Date:  2021-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.